Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The Female Cancer Screening Panel measures a range of tumour markers to provide insight into cancer risk and support early detection. This panel is ideal for women seeking proactive monitoring, particularly for breast, ovarian, gastrointestinal, and liver-related cancers.
Carcinoembryonic Antigen (CEA): Evaluates gastrointestinal and other epithelial cancer risks
CA 125: Associated with ovarian cancer monitoring
CA 199: Supports early detection of pancreatic and gastrointestinal cancers
CA 153: Linked to breast cancer risk and monitoring
Alpha-Fetoprotein (AFP): Monitors liver and certain reproductive organ tumours
Service Information
All samples are tested in CQC-regulated, UKAS-accredited laboratories. Includes mobile sample collection from your location and a comprehensive doctor review and analysis of your results.
The Female Cancer Screening Panel measures a range of tumour markers to provide insight into cancer risk and support early detection. This panel is ideal for women seeking proactive monitoring, particularly for breast, ovarian, gastrointestinal, and liver-related cancers.
Carcinoembryonic Antigen (CEA): Evaluates gastrointestinal and other epithelial cancer risks
CA 125: Associated with ovarian cancer monitoring
CA 199: Supports early detection of pancreatic and gastrointestinal cancers
CA 153: Linked to breast cancer risk and monitoring
Alpha-Fetoprotein (AFP): Monitors liver and certain reproductive organ tumours
Service Information
All samples are tested in CQC-regulated, UKAS-accredited laboratories. Includes mobile sample collection from your location and a comprehensive doctor review and analysis of your results.